Why Hire CNP Holders Rigorous designation criteria ensure CNP-designated professionals will be superior contributors to an organization's bottom-line. Customers are assured of high-quality network systems being used to develop and support products and services.
The investigational CAM2038 buprenorphine subcutaneous injection products for treatment of opioid addiction are being developed as once-weekly and once-monthly formulations, each with multiple doses, to cover all phases of treatment from initiation through maintenance.
Buprenorphine is used to ease withdrawal symptoms from opioids, and is an opioid partial agonist. Because it is a partial agonist, buprenorphine can cause the same or similar side effects as other opioids, including euphoria and respiratory depression.